Sponsor

Jaeb Center for Health Research

Clinical research sponsor

How to interpret these research links

Connected source records

The exact organization name Jaeb Center for Health Research appears in 102 distinct published trial records. The links retain registry-reported sponsor and collaborator roles; differently spelled legal entities are not automatically merged. Recruiting status describes the current published registry snapshot, not an independently verified availability guarantee.

Data basis: current published ClinicalTrials.gov records and, where present, RxNorm, MONDO and FDA-label identifiers. See the evidence interpretation and counting methodology.

Published trials102
Recruiting shown10
Roles2
SourceClinicalTrials.gov
Advertisement

Clinical trials

60 shown
Longitudinal Natural History Study of Retinal Function in Eyes of Patients With DiabetesNCT07270133 · lead sponsor · 2026-06-01
RECRUITING
Studying the Presence of CFRD Complications With Thoughtful Recruitment (SPeCTRuM)NCT06837181 · lead sponsor · 2025-09-18
RECRUITING
Effect of Inhaled Technosphere Insulin vs RAA Insulin on Exercise-Induced Hypoglycemia in Adults With T1D Using Automated Insulin DeliveryNCT06880835 · lead sponsor · 2025-06-05
RECRUITING
CGM for the Early Detection and Management of Hyperglycemia in PregnancyNCT06957028 · lead sponsor · 2025-05-27
RECRUITING
Inhaled Insulin vs Rapid-acting Injections for Post-meal Glucose Control in Women With Gestational DiabetesNCT06535789 · lead sponsor · 2025-05-01
RECRUITING
T1D Pregnancy & MeNCT06959316 · lead sponsor · 2025-04-25
ACTIVE_NOT_RECRUITING
Bionic Pancreas in CFRDNCT06449677 · lead sponsor · 2024-09-24
ACTIVE_NOT_RECRUITING
Loop T2D Observational StudyNCT05951569 · lead sponsor · 2023-06-20
COMPLETED
Time in Glucose Hospital TargetNCT05135676 · lead sponsor · 2022-05-10
COMPLETED
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 Diabetes (CLVer): Extension StudyNCT06177691 · lead sponsor · 2021-05-07
COMPLETED
Fenofibrate for Prevention of DR WorseningNCT04661358 · lead sponsor · 2021-03-05
ACTIVE_NOT_RECRUITING
Automated Insulin Delivery in Elderly With Type 1 Diabetes (AIDE T1D)NCT04016662 · lead sponsor · 2020-09-28
COMPLETED
Virtual Diabetes Specialty Clinic: A Study Evaluating Remote Initiation of Continuous Glucose MonitoringNCT04765358 · lead sponsor · 2020-08-24
COMPLETED
Hybrid Closed Loop Therapy and Verapamil for Beta Cell Preservation in New Onset Type 1 DiabetesNCT04233034 · lead sponsor · 2020-07-09
COMPLETED
The Insulin-Only Bionic Pancreas Pivotal TrialNCT04200313 · lead sponsor · 2020-03-31
COMPLETED
Surgical Idiopathic Intracranial Hypertension Treatment TrialNCT03501966 · lead sponsor · 2019-02-06
TERMINATED
The Loop Observational StudyNCT03838900 · lead sponsor · 2019-01-17
COMPLETED
CGM Intervention in Teens and Young Adults With Type 1 Diabetes (T1D)NCT03263494 · lead sponsor · 2018-01-25
COMPLETED
PROMINENT-Eye Ancillary Study (Protocol AD)NCT03345901 · lead sponsor · 2018-01-15
TERMINATED
Wireless Innovation for Seniors With Diabetes MellitusNCT03240432 · lead sponsor · 2017-09-26
COMPLETED
Day and Night Closed-loop in Young People With Type 1 DiabetesNCT02925299 · lead sponsor · 2017-05-12
COMPLETED
Strategies to Enhance New CGM Use in Early Childhood (SENCE)NCT02912728 · lead sponsor · 2017-01-30
COMPLETED
Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive Algorithms, Pump Suspension, and Insulin Dosing in Children and Young AdolescentsNCT02714972 · lead sponsor · 2016-05-01
COMPLETED
Anti-VEGF Treatment for Prevention of PDR/DMENCT02634333 · lead sponsor · 2016-01-01
COMPLETED
The Use of Mini-dose Glucagon to Prevent Exercise-induced Hypoglycemia in Type 1 DiabetesNCT02660242 · lead sponsor · 2016-01-01
COMPLETED
Mini-Dose Glucagon to Treat Non-Severe HypoglycemiaNCT02411578 · lead sponsor · 2015-09-01
COMPLETED
Reduction of Nocturnal Hypoglycemia and Hyperglycemia in the Home Using Predictive AlgorithmsNCT02438189 · lead sponsor · 2015-06-01
COMPLETED
A Trial Comparing Continuous Glucose Monitoring With and Without Routine Blood Glucose Monitoring in Adults With Type 1 DiabetesNCT02258373 · lead sponsor · 2015-03-01
COMPLETED
Pilot Study 3 of Outpatient Control-to-Range: Safety and Efficacy With Day-and-Night In-Home UseNCT02137512 · lead sponsor · 2014-08-01
COMPLETED
Insulin Clamp Ancillary Study for Assessment of Insulin ResistanceNCT02045290 · lead sponsor · 2014-01-01
COMPLETED
Metformin Therapy for Overweight Adolescents With Type 1 DiabetesNCT01881828 · lead sponsor · 2013-09-01
COMPLETED
Outpatient Reduction of Nocturnal Hypoglycemia by Using Predictive Algorithms and Pump Suspension in ChildrenNCT01823341 · lead sponsor · 2013-05-01
COMPLETED
Outpatient Pump Shutoff Pilot Feasibility and Efficacy StudyNCT01591681 · lead sponsor · 2012-11-01
COMPLETED
An Outpatient Pump Shutoff Pilot Feasibility and Safety StudyNCT01736930 · lead sponsor · 2012-01-01
COMPLETED
Effect of Diabetes Education During Retinal Ophthalmology Visits on Diabetes ControlNCT01323348 · lead sponsor · 2011-10-01
COMPLETED
Inpatient Evaluation of an Automated Closed-Loop Control-to-Range SystemNCT01271023 · lead sponsor · 2011-03-01
COMPLETED
Effect of Metabolic Control at Onset of Diabetes on Progression of Type 1 DiabetesNCT00891995 · lead sponsor · 2010-09-01
TERMINATED
Randomized Trial to Assess Efficacy and Safety of Continuous Glucose Monitoring in Children 4-<10 Years With T1DMNCT00760526 · lead sponsor · 2010-09-01
COMPLETED
Continuous Glucose Sensor Profiles in Non-Diabetic SubjectsNCT00717977 · lead sponsor · 2008-07-01
COMPLETED
A Pilot Study to Evaluate the Safety of Terbutaline in Children With Type 1 DiabetesNCT00607503 · lead sponsor · 2008-02-01
COMPLETED
Laser-Ranibizumab-Triamcinolone for Diabetic Macular EdemaNCT00444600 · lead sponsor · 2007-03-01
COMPLETED
Laser-Ranibizumab-Triamcinolone for Proliferative Diabetic RetinopathyNCT00445003 · lead sponsor · 2007-03-01
COMPLETED
The Course of Response to Focal Photocoagulation for DMENCT00442156 · lead sponsor · 2007-01-01
COMPLETED
Randomized Study of Real-Time Continuous Glucose Monitors (RT-CGM) in the Management of Type 1 DiabetesNCT00406133 · lead sponsor · 2006-12-01
COMPLETED
Hormone Responses During Hypoglycemia and the Accuracy of Continuous Glucose MonitorsNCT00607139 · lead sponsor · 2006-12-01
COMPLETED
A Phase 2 Evaluation of Anti-VEGF Therapy for Diabetic Macular Edema: Bevacizumab (Avastin)NCT00336323 · lead sponsor · 2006-06-01
COMPLETED
Effect of the Fat Content of the Bedtime Snack on Overnight HypoglycemiaNCT00493935 · lead sponsor · 2006-03-01
COMPLETED
Pilot Study of the Navigator Continuous Glucose MonitorNCT00166673 · lead sponsor · 2005-08-01
COMPLETED
Evaluation of Vitrectomy for Diabetic Macular EdemaNCT00709319 · lead sponsor · 2005-07-01
COMPLETED
The Effect of Insulin During Exercise on the Development of Low Blood Sugar in Individuals With Type I DiabetesNCT00147342 · lead sponsor · 2005-05-01
COMPLETED
Study to Determine the Relationship Between Exercise and Hypoglycemia in Children With Type 1 DiabetesNCT00109434 · lead sponsor · 2004-06-01
COMPLETED
Randomized Clinical Trial to Assess the Effectiveness of the GlucoWatch BiographerNCT00069628 · lead sponsor · 2003-07-01
COMPLETED
Pilot Study of the GlucoWatch G2 Biographer for the Management of Type 1 Diabetes in ChildrenNCT00069615 · lead sponsor · 2003-02-01
COMPLETED
Assessing Continuous Glucose Monitors in Healthy ChildrenNCT00069602 · lead sponsor · 2002-08-01
COMPLETED
Continuous Glucose Monitors for Children With Diabetes MellitusNCT00069537 · lead sponsor · 2002-05-01
COMPLETED
Safety Evaluation of MODI, an Insulin Titration Algorithm, in Adults With DiabetesNCT07599982 · collaborator · 2026-05-25
RECRUITING
Evaluation of the Fully Closed Loop Omnipod® System in Type 2 DiabetesNCT07521475 · collaborator · 2026-04-30
RECRUITING
Safety and Efficacy of Adjunct Therapies in Adults With Type 1 Diabetes: Multicenter, Registry StudyNCT07676565 · collaborator · 2026-03-24
RECRUITING
A Randomized Phase 1/2 Trial of Low Dose Anti-thymocyte Globulin (ATG) With Subsequent Adalimumab or Verapamil in New Onset Type 1 DiabetesNCT07061574 · collaborator · 2026-03-10
RECRUITING
INHALE-1st: Afrezza® For Youth With Newly-Diagnosed Type 1 DiabetesNCT07224321 · collaborator · 2026-02-04
RECRUITING

Drugs studied in this sponsor's trials

9 mapped RxNorm concepts

These drug records are connected through ClinicalTrials.gov studies listing Jaeb Center for Health Research as a sponsor, collaborator or responsible party. Each count is the number of distinct trials containing the mapped drug intervention. This does not establish that the organization manufactures, owns, sells or developed the drug.

Most studied mapped drug conceptsDistinct linked trials per RxNorm concept; one trial may study several drugs.
placebo3
acetazolamide1
adalimumab1
bevacizumab1
fenofibrate1
metformin1
ranibizumab1
terbutaline1
placebo RxCUI 8375 · Lead sponsor in 3 linked trial(s) · 0 currently recruiting 3 trials acetazolamide RxCUI 167 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial adalimumab RxCUI 327361 · Lead sponsor in 0 linked trial(s) · 1 currently recruiting 1 trial bevacizumab RxCUI 253337 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial fenofibrate RxCUI 8703 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial metformin RxCUI 6809 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial ranibizumab RxCUI 595060 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial terbutaline RxCUI 10368 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial triamcinolone acetonide RxCUI 10761 · Lead sponsor in 1 linked trial(s) · 0 currently recruiting 1 trial

Sponsor roles

lead sponsor55
collaborator47
Advertisement

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.